Search

Search bills, members, committees and pages...

H.R. 4668

U.S. HouseIn House Committee

Summary

H.R. 4668, the End the Vaccine Carveout Act, was introduced in the House on Jul 23, 2025 by Rep. Paul Gosar (R) with 30 co-sponsors. It was referred to Energy And Commerce, and last saw action on Jul 23, 2025: Referred to the House Committee on Energy and Commerce.


Record

Text

H.R. 4668 has 30 co-sponsors.

hb4668/introduced-in-house.txt
119 HR 4668 IH: End the Vaccine Carveout Act
U.S. House of Representatives
2025-07-23
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 1st Session H. R. 4668 IN THE HOUSE OF REPRESENTATIVES July 23, 2025 Mr. Gosar (for himself, Mr. Biggs of Arizona , Ms. Boebert , Mr. Brecheen , Mr. Burchett , Mr. Burlison , Mr. Collins , Mr. Crane , Mr. Davidson , Mr. Donalds , Ms. Greene of Georgia , Ms. Hageman , Mr. Harris of Maryland , Mr. Higgins of Louisiana , Mr. Jackson of Texas , Mrs. Luna , Ms. Mace , Mr. Massie , Mrs. Miller of Illinois , Mr. Mills , Mr. Moore of Alabama , Mr. Nehls , Mr. Norman , Mr. Ogles , Mr. Roy , Mr. Self , Mrs. Spartz , Mr. Steube , and Mr. Weber of Texas ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL
To amend the Public Health Service Act to end the liability shield for vaccine manufacturers, and for other purposes.
1.
Short title
This Act may be cited as the End the Vaccine Carveout Act .
2.
Ending liability shield for vaccine manufacturers
(a)
National Vaccine Injury Compensation Program
(1)
Petitions for compensation
Section 2111 of the Public Health Service Act ( 42 U.S.C. 300aa–11 ) is amended—
(A)
in subsection (a)—
(i)
by striking paragraphs (2), (3), (5), and (6);
(ii)
by inserting after paragraph (1) the following:
(2)
Beginning on the date of enactment of the End the Vaccine Carveout Act , and subject to paragraph (4)(B), irrespective of whether a person has filed a petition for compensation under the Program in relation to a vaccine-related injury or death, such person may bring a civil action against a vaccine administrator or manufacturer in a State or Federal court for damages arising from such injury or death.
;
(iii)
by redesignating paragraph (4) as paragraph (3);
(iv)
by redesignating paragraphs (7) through (10) as paragraphs (4) through (7), respectively; and
(v)
by amending paragraph (4) (as so redesignated) to read as follows:
(4)
(A)
If in a civil action brought against a vaccine administrator or manufacturer for a vaccine-related injury or death damages are awarded under a judgment of a court or a settlement of such action, the person who brought such action may not file a petition under subsection (b) for such injury or death, and any pending petition for such injury or death shall be dismissed.
(B)
If compensation is awarded for a petition filed under the Program for a vaccine-related injury or death, the person who filed such petition may not bring a civil action against a vaccine administrator or manufacturer for such injury or death, and any pending civil action for such injury or death shall be dismissed.
; and
(B)
in subsection (c)(1)(B)(i)(III), by striking not later than 6 months .
(2)
Limitations of actions
(A)
In general
Section 2116 of the Public Health Service Act ( 42 U.S.C. 300aa–16 ) is amended—
(i)
in subsection (a)—
(I)
in paragraph (2), by striking no petition may be filed for compensation under the Program for such injury after the expiration of 36 months after the date of the occurrence of the first symptom or manifestation of onset or of the significant aggravation of such injury and inserting unless prohibited by section 2111(a)(4)(A), a petition may be filed for compensation under the Program for such injury at any time ; and
(II)
in paragraph (3), by striking no petition may be filed for compensation under the Program for such death after the expiration of 24 months from the date of the death and no such petition may be filed more than 48 months after the date of the occurrence of the first symptom or manifestation of onset or of the significant aggravation of the injury from which the death resulted and inserting unless prohibited by section 2111(a)(4)(A), a petition may be filed for compensation under the Program for such death at any time ; and
(ii)
in subsection (b)—
(I)
by striking notwithstanding section 2111(b)(2) and inserting notwithstanding section 2111(b)(2), and unless prohibited by section 2111(a)(4)(A) ;
(II)
by striking not later than 2 years after the effective date of the revision and inserting at any time ;
(III)
by striking table if— and inserting table if such vaccine-related injury or death occurred before the effective date of this part. ; and
(IV)
by striking paragraphs (1) and (2).
(B)
Retroactivity
The amendments made by subparagraph (A) shall apply as if included in the enactment of section 2116 of the Public Health Service Act ( 42 U.S.C. 300aa–16 ).
(3)
Repeals
(A)
Election
Section 2121(a) of the Public Health Service Act ( 42 U.S.C. 300aa–21(a) ) is repealed.
(B)
Standards of responsibility
Section 2122 of the Public Health Service Act ( 42 U.S.C. 300aa–22 ) is repealed.
(C)
Trial
Section 2123 of the Public Health Service Act ( 42 U.S.C. 300aa–23 ) is repealed.
(4)
Conforming amendments
(A)
Attorneys’ fees
Section 2115(e) of the Public Health Service Act ( 42 U.S.C. 300aa–15(e) ) is amended—
(i)
by striking paragraph (2); and
(ii)
by redesignating paragraph (3) as paragraph (2).
(B)
Payment of compensation
Section 2115(f) of the Public Health Service Act ( 42 U.S.C. 300aa–15(f) ) is amended—
(i)
by striking paragraph (1);
(ii)
by redesignating paragraphs (2) through (4) as paragraphs (1) through (3), respectively;
(iii)
in paragraph (1) (as so redesignated), by striking Such compensation may not be paid after an election under section 2121(a) to file a civil action for damages for the vaccine-related injury or death for which such compensation was awarded. ; and
(iv)
in paragraph (3)(B) (as so redesignated), by striking If the appropriations under subsection (j) are insufficient to make a payment of an annual installment, the limitation on civil actions prescribed by section 2121(a) shall not apply to a civil action for damages brought by the petitioner entitled to the payment. .
(C)
State limitations of actions
Section 2116(c) of the Public Health Service Act ( 42 U.S.C. 300aa–16(c) ) is amended by striking an election is made under section 2121(a) to file the civil action and inserting judgment is entered by the United States Court of Federal Claims (or, if an appeal is taken under section 2112(f), the appellate court’s mandate is issued) with respect to the petition .
(D)
Termination of program
Section 2134(b)(1) of the Public Health Service Act ( 42 U.S.C. 300aa–34(b)(1) ) is amended—
(i)
by striking and accepted under section 2121(a) ; and
(ii)
by striking Section 2111(a) and part B shall not apply to civil actions for damages for a vaccine-related injury or death for which a petition may not be filed because of subparagraph (B). .
(b)
Excluding COVID–19 vaccines from definition of covered countermeasure
Section 319F–3(i)(1) of the Public Health Service Act (42 U.S.C. 247d–6d(i)(1)) is amended to read as follows:
(1)
Covered countermeasure
The term covered countermeasure —
(A)
means—
(i)
a qualified pandemic or epidemic product (as defined in paragraph (7));
(ii)
a security countermeasure (as defined in section 319F–2(c)(1)(B));
(iii)
a drug (as such term is defined in section 201(g)(1)) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(g)(1) ), biological product (as such term is defined by section 351(i) of this Act), or device (as such term is defined by section 201(h) of the Federal Food, Drug and Cosmetic Act ( 21 U.S.C. 321(h) )) that is authorized for emergency use in accordance with section 564, 564A, or 564B of the Federal Food, Drug, and Cosmetic Act; or
(iv)
a respiratory protective device that is approved by the National Institute for Occupational Safety and Health under part 84 of title 42, Code of Federal Regulations (or any successor regulations), and that the Secretary determines to be a priority for use during a public health emergency declared under section 319; and
(B)
does not include any vaccine used to mitigate, prevent, or treat COVID–19.
.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-07-23
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Introduced in House Jul 23, 2025

hb4668/introduced-in-house.md

Shown Here:
Introduced in House (07/23/2025)

End the Vaccine Carveout Act

This bill removes liability protections for manufacturers and administrators for vaccine-related injuries, and removes limitations on bringing civil actions for vaccine-related injuries or seeking compensation, under the National Vaccine Injury Compensation Program (VICP). It also excludes COVID-19 vaccines from liability protections under the Countermeasures Injury Compensation Program (CICP).

Under current law, the VICP provides compensation for alleged injuries caused by certain routinely administered vaccines. Individuals generally may not file a civil action in court unless a VICP claim is filed and the resulting judgement is rejected. The VICP also limits the types of claims and amount of damages that may be sought (e.g., no liability for unavoidable side effects or failure to directly warn), and it imposes deadlines for filing claims. The bill removes the requirement to first file a claim under the VICP before pursuing a civil action, so individuals alleging vaccine-related injuries may choose to either bring a civil action or utilize the VICP. It also removes the restrictions on the types of civil actions and damages. The bill also removes the deadlines for filing claims under the VICP and applies this change retroactively.

Additionally, under current law, the CICP provides compensation for alleged injuries caused by certain medical countermeasures during public health emergencies, including COVID-19 vaccines. The bill excludes COVID-19 vaccines from being considered as medical countermeasures. Therefore, under the bill, individuals may file civil actions against manufacturers of COVID-19 vaccines rather than filing claims under the CICP.

Sponsors

Rep. Paul Gosar (R) sponsors H.R. 4668, and 30 members have co-sponsored it, 28 of them from the day it was introduced.

Committees

H.R. 4668 went before 1 committee: Energy and Commerce.

Energy and Commerce
Energy and Commerce
Referred To · Jul 23, 2025 · 1,636 Bills

Actions

H.R. 4668 has taken 2 actions since Jul 23, 2025.

ChamberAction
Jul 23, 2025
House
Introduced in House
Jul 23, 2025
House
Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee

Votes

H.R. 4668 has not gone to a roll call.

1 bill is related to H.R. 4668.

Titles

H.R. 4668 goes by 3 titles, 1 of them short titles.

  • End the Vaccine Carveout Act — Display Title
  • To amend the Public Health Service Act to end the liability shield for vaccine manufacturers, and for other purposes. — Official Title as Introduced
  • End the Vaccine Carveout Act — Short Title(s) as Introduced

Lobbying

3 clients hired 3 firms and 11 registered lobbyists who named H.R. 4668 in 8 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Budget/Appropriations, Immigration, Health Issues, Banking, Consumer Issues/Safety/Products, Environment/Superfund, Financial Institutions/Investments/Securities, Foreign Relations.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
ASSOCIATED GENERAL CONTRACTORS OF AMERICAVirginia16
UNIVERSITY OF ILLINOISIllinois11
UNIVERSITY OF OREGONOregon11

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
ASSOCIATED GENERAL CONTRACTORS OF AMERICAASSOCIATED GENERAL CONTRACTORS OF AMERICA2026 second_quarter$216.4K2nd Quarter - Report
ASSOCIATED GENERAL CONTRACTORS OF AMERICAASSOCIATED GENERAL CONTRACTORS OF AMERICA2025 fourth_quarter$202.2K4th Quarter - Report
ASSOCIATED GENERAL CONTRACTORS OF AMERICAASSOCIATED GENERAL CONTRACTORS OF AMERICA2026 first_quarter$195.9K1st Quarter - Report
ASSOCIATED GENERAL CONTRACTORS OF AMERICAASSOCIATED GENERAL CONTRACTORS OF AMERICA2025 first_quarter$120K1st Quarter - Report
ASSOCIATED GENERAL CONTRACTORS OF AMERICAASSOCIATED GENERAL CONTRACTORS OF AMERICA2025 second_quarter$111.2K2nd Quarter - Report
ASSOCIATED GENERAL CONTRACTORS OF AMERICAASSOCIATED GENERAL CONTRACTORS OF AMERICA2025 third_quarter$76.9K3rd Quarter - Report
UNIVERSITY OF OREGONUNIVERSITY OF OREGON2026 second_quarter$55K2nd Quarter - Report
UNIVERSITY OF ILLINOISUNIVERSITY OF ILLINOIS2026 second_quarter$50K2nd Quarter - Report

Classification

The Congressional Research Service files H.R. 4668 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 4668’s is Health.

hr4668/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 4668, as entered in the Congressional Record.

[Congressional Record Volume 171, Number 126 (Wednesday, July 23, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. GOSAR:H.R. 4668.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H3648]

Source: congress.gov · legiscan.com